Envía por correo este artículo 
Índice triglicéridos -glucosa y su asociación al riesgo cardiometabólico: Una mini revisión de alcance
Resumen
El índice de triglicéridos-glucosa (TyG) se considera un factor fundamental para diversas enfermedades metabólicas, cardiovasculares y cerebrovasculares. Sin embargo, actualmente hay pocos estudios sobre la asociación entre el índice TyG y el riesgo de enfermedades cardiometabólicas (ECM). El objetivo de esta revisión es fue explorar el riesgo de ECM en relación con el nivel a largo plazo y el cambio del índice TyG. Se aplicó un diseño documental tipo descriptivo y se realizó una búsqueda bibliográfica en las bases de datos PubMed, Redalyc, SciELO, Google Scholar, Science Direct y Cochrane Library. Se seleccionaron 74 artículos publicados entre los años 2019 a 2024. El nivel elevado a largo plazo y el cambio del índice TyG son factores de riesgo para la aparición de ECM, con un valor potencial para optimizar la estratificación del riesgo de ECV en la población general. Los estudios futuros deberían centrarse en diseños multicéntricos y multirregionales para explorar más a fondo la relación entre las ECM y el índice TyG en especial lo referente a ingesta y hábitos nutricionales. Como método novedoso, se espera que el índice TyG se convierta en un índice alternativo a la prueba de pinzamiento hiperinsulinémica-euglucémica (HIEC), un método tradicional para evaluar la sensibilidad y resistencia a la insulina.
Palabras clave
Referencias
Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuñiga FA. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018;17(1):122. doi: 10.1186/s12933-018-0762-4. PMID: 30170598; PMCID: PMC6119242.
DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979; 237(3):E214-23. doi: 10.1152/ajpendo.1979.237.3.E214. PMID: 382871.
Attaye I, Pinto-Sietsma SJ, Herrema H, Nieuwdorp M. A Crucial Role for Diet in the Relationship Between Gut Microbiota and Cardiometabolic Disease. Annu Rev Med. 2020; 71:149-161. doi: 10.1146/annurev-med-062218-023720. PMID: 31479620.
Roa-Díaz ZM, Raguindin PF, Bano A, Laine JE, Muka T, Glisic M. Menopause and cardiometabolic diseases: What we (don't) know and why it matters. Maturitas. 2021; 152:48-56. doi: 10.1016/j.maturitas.2021.06.013. PMID: 34674807.
Yuan Y, Zhou B, Wang S, Ma J, Dong F, Yang M, Zhang Z, Niu W. Adult Body Height and Cardiometabolic Disease Risk: The China National Health Survey in Shaanxi. Front Endocrinol (Lausanne). 2020; 11:587616. doi: 10.3389/fendo.2020.587616. PMID: 33408690; PMCID: PMC7780292.
Organización Mundial de la Salud/Organización Panamericana de la Salud. Enfermedades cardiovasculares. 2023. Disponible en: https://www.paho.org/es/temas/enfermedades-cardiovasculares
Wang Y, Wang H, Howard AG, Adair LS, Popkin BM, Su C, Du W, Zhang B, Gordon-Larsen P. Six-Year Incidence of Cardiometabolic Risk Factors in a Population-Based Cohort of Chinese Adults Followed From 2009 to 2015. J Am Heart Assoc. 2019; 8(12): e011368. doi: 10.1161/JAHA.118.011368. PMID: 31165668; PMCID: PMC6645625.
Sattar N, Gill JMR, Alazawi W. Improving prevention strategies for cardiometabolic disease. Nat Med. 2020;26(3):320-325. doi: 10.1038/s41591-020-0786-7. PMID: 32152584.
Zhao X, Wang Y, Chen R, Li J, Zhou J, Liu C, Zhou P, Sheng Z, Chen Y, Song L, Zhao H, Yan H. Triglyceride glucose index combined with plaque characteristics as a novel biomarker for cardiovascular outcomes after percutaneous coronary intervention in ST-elevated myocardial infarction patients: an intravascular optical coherence tomography study. Cardiovasc Diabetol. 2021;20(1):131. doi: 10.1186/s12933-021-01321-7. PMID: 34183007; PMCID: PMC8240222.
Köktürk U, Önalan O, Somuncu MU, Akgül Ö, Uygur B, Püşüroğlu H. Impact of triglyceride-glucose index on intracoronary thrombus burden in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention. Nutr Metab Cardiovasc Dis. 2024; 34(4):860-867. doi: 10.1016/j.numecd.2023.12.025. PMID: 38336545.
Brito ADM, Hermsdorff HHM, Filgueiras MS, Vieira-Ribeiro SA, Franceschini SDCC, Novaes JF. TAG-glucose (TyG) index in childhood: an estimate of cut-off points and the relation to cardiometabolic risk in 4- to 9-year-old children. Public Health Nutr. 2021; 24(9):2603-2610. doi: 10.1017/S1368980020000944. PMID: 32624056; PMCID: PMC10195534.
Tahapary DL, Pratisthita LB, Fitri NA, Marcella C, Wafa S, Kurniawan F, Rizka A, Tarigan TJE, Harbuwono DS, Purnamasari D, Soewondo P. Challenges in the diagnosis of insulin resistance: Focusing on the role of HOMA-IR and Tryglyceride/glucose index. Diabetes Metab Syndr. 2022;16(8):102581. doi: 10.1016/j.dsx.2022.102581. PMID: 35939943.
Sánchez-García A, Rodríguez-Gutiérrez R, Mancillas-Adame L, González-Nava V, Díaz González-Colmenero A, Solis RC, Álvarez-Villalobos NA, González-González JG. Diagnostic Accuracy of the Triglyceride and Glucose Index for Insulin Resistance: A Systematic Review. Int J Endocrinol. 2020; 2020:4678526. doi: 10.1155/2020/4678526. PMID: 32256572; PMCID: PMC7085845.
Min Y, Wei X, Wei Z, Song G, Zhao X, Lei Y. Prognostic effect of triglyceride glucose-related parameters on all-cause and cardiovascular mortality in the United States adults with metabolic dysfunction-associated steatotic liver disease. Cardiovasc Diabetol. 2024; 23(1):188. doi: 10.1186/s12933-024-02287-y. PMID: 38824550; PMCID: PMC11144336.
Guo W, Qin P, Lu J, Li X, Zhu W, Xu N, Wang J, Zhang Q. Diagnostic values and appropriate cutoff points of lipid ratios in patients with abnormal glucose tolerance status: a cross-sectional study. Lipids Health Dis. 2019;18(1):130. doi: 10.1186/s12944-019-1070-z. PMID: 31153374; PMCID: PMC6545201.
Gong R, Liu Y, Luo G, Liu W, Jin Z, Xu Z, Li Z, Yang L, Wei X. Associations of TG/HDL Ratio with the Risk of Prediabetes and Diabetes in Chinese Adults: A Chinese Population Cohort Study Based on Open Data. Int J Endocrinol. 2021; :9949579. doi: 10.1155/2021/9949579. PMID: 34306073; PMCID: PMC8282372.
Yuge H, Okada H, Hamaguchi M, Kurogi K, Murata H, Ito M, Fukui M. Triglycerides/HDL cholesterol ratio and type 2 diabetes incidence: Panasonic Cohort Study 10. Cardiovasc Diabetol. 2023;22(1):308. doi: 10.1186/s12933-023-02046-5. PMID: 37940952; PMCID: PMC10634002.
Wang A, Tian X, Zuo Y, Chen S, Meng X, Wu S, Wang Y. Change in triglyceride-glucose index predicts the risk of cardiovascular disease in the general population: a prospective cohort study. Cardiovasc Diabetol. 2021; 20(1):113. doi: 10.1186/s12933-021-01305-7. PMID: 34039351; PMCID: PMC8157734.
Park B, Lee HS, Lee YJ. Triglyceride glucose (TyG) index as a predictor of incident type 2 diabetes among nonobese adults: a 12-year longitudinal study of the Korean Genome and Epidemiology Study cohort. Transl Res. 2021; 228:42-51. doi: 10.1016/j.trsl.2020.08.003. PMID: 32827706.
Peradze N, Farr OM, Mantzoros CS. Research developments in metabolism 2018. Metabolism. 2019; 91:70-79. doi: 10.1016/j.metabol.2018.11.011. PMID: 30503805.
Ibrahim AH, Hammad AM, Al-Qerem W, Alaqabani H, Hall FS, Alasmari F. Triglyceride Glucose Index as an Indicator of Cardiovascular Risk in Syrian Refugees. Diabetes Metab Syndr Obes. 2024; 17:1403-1414. doi: 10.2147/DMSO.S455050. PMID: 38533267; PMCID: PMC10964780.
Song S, Choi SY, Park HE, Han HW, Park SH, Sung J, Jung HO, Sung JM, Chang HJ. Incremental prognostic value of triglyceride glucose index additional to coronary artery calcium score in asymptomatic low-risk population. Cardiovasc Diabetol. 2022; 21(1):193. doi: 10.1186/s12933-022-01620-7. PMID: 36151571; PMCID: PMC9508773.
Bala C, Gheorghe-Fronea O, Pop D, Pop C, Caloian B, Comsa H, Bozan C, Matei C, Dorobantu M. The Association Between Six Surrogate Insulin Resistance Indexes and Hypertension: A Population-Based Study. Metab Syndr Relat Disord. 2019;17(6):328-333. doi: 10.1089/met.2018.0122. PMID: 31034338.
Nam KW, Kwon HM, Jeong HY, Park JH, Kwon H, Jeong SM. High triglyceride-glucose index is associated with subclinical cerebral small vessel disease in a healthy population: a cross-sectional study. Cardiovasc Diabetol. 2020; 19(1):53. doi: 10.1186/s12933-020-01031-6. PMID: 32375783; PMCID: PMC7201807.
Zhang K, Han Y, Gao YX, Gu FM, Cai T, Gu ZX, Yu ZJ, Min G, Gao YF, Hu R, Huang MX. Association between the triglyceride glucose index and length of hospital stay in patients with heart failure and type 2 diabetes in the intensive care unit: a retrospective cohort study. Front Endocrinol (Lausanne). 2024; 15:1354614. doi: 10.3389/fendo.2024.1354614. PMID: 38800470; PMCID: PMC11127565.
Loh HC, Lim R, Lee KW, Ooi CY, Chuan DR, Looi I, Kah Hay Y, Abdul Karim Khan N. Effects of vitamin E on stroke: a systematic review with meta-analysis and trial sequential analysis. Stroke Vasc Neurol. 2021;6(1):109-120. doi: 10.1136/svn-2020-000519. PMID: 33109618; PMCID: PMC8005911.
Ontano M, Mejía-Velastegui AI, Avilés-Arroyo ME. Principios bioéticos y su aplicación en las investigaciones médico-científicas: Artículo de revisión. Rev Cien Ec. 2021; 3(3):9-16. https://doi.org/10.23936/rce.v3i3.27
Jiao Y, Su Y, Shen J, Hou X, Li Y, Wang J, Liu B, Qiu D, Sun Z, Chen Y, Xi Q, Shen M, Fu Z. Evaluation of the long-term prognostic ability of triglyceride-glucose index for elderly acute coronary syndrome patients: a cohort study. Cardiovasc Diabetol. 2022; 21(1):3. doi: 10.1186/s12933-021-01443-y. PMID: 34991602; PMCID: PMC8740408.
Sánchez-García A, Rodríguez-Gutiérrez R, Mancillas-Adame L, González-Nava V, Díaz González-Colmenero A, Solis RC, Álvarez-Villalobos NA, González-González JG. Diagnostic Accuracy of the Triglyceride and Glucose Index for Insulin Resistance: A Systematic Review. Int J Endocrinol. 2020; 2020:4678526. doi: 10.1155/2020/4678526. PMID: 32256572; PMCID: PMC7085845.
Guerrero-Romero F, Simental-Mendía LE, González-Ortiz M, Martínez-Abundis E, Ramos-Zavala MG, Hernández-González SO, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010; 95(7):3347-51. doi: 10.1210/jc.2010-0288. PMID: 20484475.
Tao LC, Xu JN, Wang TT, Hua F, Li JJ. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Cardiovasc Diabetol. 2022; 21(1):68. doi: 10.1186/s12933-022-01511-x. PMID: 35524263; PMCID: PMC9078015.
Sacco RL, Roth GA, Reddy KS, Arnett DK, Bonita R, Gaziano TA, et al. The Heart of 25 by 25: Achieving the goal of reducing global and regional premature deaths from cardiovascular diseases and stroke: A modeling study from the American Heart Association and World Heart Federation. Circulation. 2016; 133(23): e674-90. doi: 10.1161/CIR.0000000000000395. PMID: 27162236.
Rosenblit PD. Extreme Atherosclerotic Cardiovascular Disease (ASCVD) Risk Recognition. Curr Diab Rep. 2019; 19(8):61. doi: 10.1007/s11892-019-1178-6. Erratum in: Curr Diab Rep. 2019;19(11):123. PMID: 31332544.
Choi S. The Potential Role of Biomarkers Associated with ASCVD Risk: Risk-Enhancing Biomarkers. J Lipid Atheroscler. 2019;8(2):173-182. doi: 10.12997/jla.2019.8.2.173. PMID: 32821707; PMCID: PMC7379121
Tian X, Zuo Y, Chen S, Liu Q, Tao B, Wu S, Wang A. Triglyceride-glucose index is associated with the risk of myocardial infarction: an 11-year prospective study in the Kailuan cohort. Cardiovasc Diabetol. 2021; 20(1):19. doi: 10.1186/s12933-020-01210-5. PMID: 33435964; PMCID: PMC7802156.
da Silva A, Caldas APS, Hermsdorff HHM, Bersch-Ferreira ÂC, Torreglosa CR, Weber B, Bressan J. Triglyceride-glucose index is associated with symptomatic coronary artery disease in patients in secondary care. Cardiovasc Diabetol. 2019; 18(1):89. doi: 10.1186/s12933-019-0893-2. PMID: 31296225; PMCID: PMC6625050.
Neglia D, Aimo A, Lorenzoni V, Caselli C, Gimelli A. Triglyceride-glucose index predicts outcome in patients with chronic coronary syndrome independently of other risk factors and myocardial ischaemia. Eur Heart J Open. 2021; 1(1): oeab004. doi: 10.1093/ehjopen/oeab004. PMID: 35919094; PMCID: PMC9242059.
Wang L, Cong HL, Zhang JX, Hu YC, Wei A, Zhang YY, Yang H, Ren LB, Qi W, Li WY, Zhang R, Xu JH. Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome. Cardiovasc Diabetol. 2020;19(1):80. doi: 10.1186/s12933-020-01054-z. PMID: 32534586; PMCID: PMC7293784.
Akbar MR, Pranata R, Wibowo A, Irvan, Sihite TA, Martha JW. The association between triglyceride-glucose index and major adverse cardiovascular events in patients with acute coronary syndrome - dose-response meta-analysis. Nutr Metab Cardiovasc Dis. 2021;31(11):3024-3030. doi: 10.1016/j.numecd.2021.08.026. PMID: 34625361.
Hu C, Zhang J, Liu J, Liu Y, Gao A, Zhu Y, Zhao Y. Discordance between the triglyceride glucose index and fasting plasma glucose or HbA1C in patients with acute coronary syndrome undergoing percutaneous coronary intervention predicts cardiovascular events: a cohort study from China. Cardiovasc Diabetol. 2020; 19(1):116. doi: 10.1186/s12933-020-01091-8. PMID: 32703284; PMCID: PMC7379768.
Zhao Q, Zhang TY, Cheng YJ, Ma Y, Xu YK, Yang JQ, Zhou YJ. Impacts of triglyceride-glucose index on prognosis of patients with type 2 diabetes mellitus and non-ST-segment elevation acute coronary syndrome: results from an observational cohort study in China. Cardiovasc Diabetol. 2020;19(1):108. doi: 10.1186/s12933-020-01086-5. PMID: 32641127; PMCID: PMC7341665.
Ding X, Wang X, Wu J, Zhang M, Cui M. Triglyceride-glucose index and the incidence of atherosclerotic cardiovascular diseases: a meta-analysis of cohort studies. Cardiovasc Diabetol. 2021; 20(1):76. doi: 10.1186/s12933-021-01268-9. PMID: 33812373; PMCID: PMC8019501.
Kim J, Shin SJ, Kang HT. The association between triglyceride-glucose index, cardio-cerebrovascular diseases, and death in Korean adults: A retrospective study based on the NHIS-HEALS cohort. PLoS One. 2021; 16(11): e0259212. doi: 10.1371/journal.pone.0259212. PMID: 34735502; PMCID: PMC8568280.
Cho YK, Lee J, Kim HS, Kim EH, Lee MJ, Yang DH, Kang JW, Jung CH, Park JY, Kim HK, Lee WJ. Triglyceride Glucose-Waist Circumference Better Predicts Coronary Calcium Progression Compared with Other Indices of Insulin Resistance: A Longitudinal Observational Study. J Clin Med. 2020; 10(1):92. doi: 10.3390/jcm10010092. PMID: 33383953; PMCID: PMC7795085.
Zhao Q, Zhang TY, Cheng YJ, Ma Y, Xu YK, Yang JQ, Zhou YJ. Triglyceride-Glucose Index as a Surrogate Marker of Insulin Resistance for Predicting Cardiovascular Outcomes in Nondiabetic Patients with Non-ST-Segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. J Atheroscler Thromb. 2021;28(11):1175-1194. doi: 10.5551/jat.59840. PMID: 33191314; PMCID: PMC8592700.
Barzegar N, Tohidi M, Hasheminia M, Azizi F, Hadaegh F. The impact of triglyceride-glucose index on incident cardiovascular events during 16 years of follow-up: Tehran Lipid and Glucose Study. Cardiovasc Diabetol. 2020;19(1):155. doi: 10.1186/s12933-020-01121-5. PMID: 32993633; PMCID: PMC7526412.
Liu Q, Cui H, Ma Y, Han X, Cao Z, Wu Y. Triglyceride-glucose index associated with the risk of cardiovascular disease: the Kailuan study. Endocrine. 2022; 75(2):392-399. doi: 10.1007/s12020-021-02862-3. PMID: 34542800.
Liu L, Wu Z, Zhuang Y, Zhang Y, Cui H, Lu F, Peng J, Yang J. Association of triglyceride-glucose index and traditional risk factors with cardiovascular disease among non-diabetic population: a 10-year prospective cohort study. Cardiovasc Diabetol. 2022; 21(1):256. doi: 10.1186/s12933-022-01694-3. PMID: 36434636; PMCID: PMC9700958.
Wang A, Wang G, Liu Q, Zuo Y, Chen S, Tao B, Tian X, Wang P, Meng X, Wu S, Wang Y, Wang Y. Triglyceride-glucose index and the risk of stroke and its subtypes in the general population: an 11-year follow-up. Cardiovasc Diabetol. 2021; 20(1):46. doi: 10.1186/s12933-021-01238-1. PMID: 33602208; PMCID: PMC7893902.
Chamroonkiadtikun P, Ananchaisarp T, Wanichanon W. The triglyceride-glucose index, a predictor of type 2 diabetes development: A retrospective cohort study. Prim Care Diabetes. 2020; 14(2):161-167. doi: 10.1016/j.pcd.2019.08.004. PMID: 31466834.
Ramdas Nayak VK, Satheesh P, Shenoy MT, Kalra S. Triglyceride Glucose (TyG) Index: A surrogate biomarker of insulin resistance. J Pak Med Assoc. 2022;72(5):986-988. doi: 10.47391/JPMA.22-63. PMID: 35713073.
Khan SH, Khan AN, Chaudhry N, Anwar R, Fazal N, Tariq M. Comparison of various steady state surrogate insulin resistance indices in diagnosing metabolic syndrome. Diabetol Metab Syndr. 2019; 11:44. doi: 10.1186/s13098-019-0439-5. PMID: 31223343; PMCID: PMC6570930.
Katta N, Loethen T, Lavie CJ, Alpert MA. Obesity and Coronary Heart Disease: Epidemiology, Pathology, and Coronary Artery Imaging. Curr Probl Cardiol. 2021; 46(3):100655. doi: 10.1016/j.cpcardiol.2020.100655. PMID: 32843206.
Hill MA, Yang Y, Zhang L, Sun Z, Jia G, Parrish AR, Sowers JR. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism. 2021; 119:154766. doi: 10.1016/j.metabol.2021.154766. PMID: 33766485.
Liu C, Liang D, Xiao K, Xie L. Association between the triglyceride-glucose index and all-cause and CVD mortality in the young population with diabetes. Cardiovasc Diabetol. 2024;23(1):171. doi: 10.1186/s12933-024-02269-0. PMID: 38755682; PMCID: PMC11097545.
Abel ED. Insulin signaling in the heart. Am J Physiol Endocrinol Metab. 2021; 321(1): E130-E145. doi: 10.1152/ajpendo.00158.2021. PMID: 34056923; PMCID: PMC8321827.
Kuppuswami J, Senthilkumar GP. Nutri-stress, mitochondrial dysfunction, and insulin resistance-role of heat shock proteins. Cell Stress Chaperones. 2023; 28(1):35-48. doi: 10.1007/s12192-022-01314-9. PMID: 36441381; PMCID: PMC9877269.
Shi Y, Duan H, Liu J, Shi X, Zhao M, Zhang Y. Association of triglyceride glucose index with the risk of acute kidney injury in patients with coronary revascularization: a cohort study. Diabetol Metab Syndr. 2024;16(1):117. doi: 10.1186/s13098-024-01358-0. PMID: 38807249; PMCID: PMC11131318.
Haye A, Ansari MA, Rahman SO, Shamsi Y, Ahmed D, Sharma M. Role of AMP-activated protein kinase on cardio-metabolic abnormalities in the development of diabetic cardiomyopathy: A molecular landscape. Eur J Pharmacol. 2020; 888:173376. doi: 10.1016/j.ejphar.2020.173376. PMID: 32810493.
Li ZP, Chen J, Xin Q, Pei XY, Wu HL, Tan ZX. Triglyceride glucose-body mass index as a novel predictor of slow coronary flow phenomenon in patients with ischemia and nonobstructive coronary arteries (INOCA). BMC Cardiovasc Disord. 2024; 24(1):60. doi: 10.1186/s12872-024-03722-4. PMID: 38243161; PMCID: PMC10797862.
Łupińska A, Aszkiełowicz S, Kowalik D, Jeziorny K, Kolasa-Kicińska M, Smalczewska P, Zygmunt A, Lewiński A, Stawerska R. Comparison of the Clinical Utility of Two Insulin Resistance Indices: IRI-HOMA and IRI-Belfiore in Diagnosing Insulin Resistance and Metabolic Complications in Children Based on the Results Obtained for the Polish Population. J Clin Med. 2024;13(10):2865. doi: 10.3390/jcm13102865. PMID: 38792408; PMCID: PMC11122103.
Ala-Korpela M. The culprit is the carrier, not the loads: cholesterol, triglycerides and apolipoprotein B in atherosclerosis and coronary heart disease. Int J Epidemiol. 2019; 48(5):1389-1392. doi: 10.1093/ije/dyz068. PMID: 30968109.
Martemucci G, Fracchiolla G, Muraglia M, Tardugno R, Dibenedetto RS, D'Alessandro AG. Metabolic Syndrome: A Narrative Review from the Oxidative Stress to the Management of Related Diseases. Antioxidants (Basel). 2023; 12(12):2091. doi: 10.3390/antiox12122091. PMID: 38136211; PMCID: PMC10740837.
An Y, Wang X, Guan X, Yuan P, Liu Y, Wei L, Wang F, Qi X. Endoplasmic reticulum stress-mediated cell death in cardiovascular disease. Cell Stress Chaperones. 2024; 29(1):158-174. doi: 10.1016/j.cstres.2023.12.003. PMID: 38295944; PMCID: PMC10939083.
Tahapary DL, Pratisthita LB, Fitri NA, Marcella C, Wafa S, Kurniawan F, Rizka A, Tarigan TJE, Harbuwono DS, Purnamasari D, Soewondo P. Challenges in the diagnosis of insulin resistance: Focusing on the role of HOMA-IR and Tryglyceride/glucose index. Diabetes Metab Syndr. 2022; 16(8):102581. doi: 10.1016/j.dsx.2022.102581. PMID: 35939943.
Cho YR, Ann SH, Won KB, Park GM, Kim YG, Yang DH, Kang JW, Lim TH, Kim HK, Choe J, Lee SW, Kim YH, Kim SJ, Lee SG. Association between insulin resistance, hyperglycemia, and coronary artery disease according to the presence of diabetes. Sci Rep. 2019;9(1):6129. doi: 10.1038/s41598-019-42700-1. PMID: 31477741; PMCID: PMC6718672.
Moon JH, Kim Y, Oh TJ, Moon JH, Kwak SH, Park KS, Jang HC, Choi SH, Cho NH. Triglyceride-Glucose Index Predicts Future Atherosclerotic Cardiovascular Diseases: A 16-Year Follow-up in a Prospective, Community-Dwelling Cohort Study. Endocrinol Metab (Seoul). 2023; 38(4):406-417. doi: 10.3803/EnM.2023.1703. PMID: 37533176; PMCID: PMC10475965.
Cui H, Liu Q, Wu Y, Cao L. Cumulative triglyceride-glucose index is a risk for CVD: a prospective cohort study. Cardiovasc Diabetol. 2022; 21(1):22. doi: 10.1186/s12933-022-01456-1. PMID: 35144621; PMCID: PMC8830002.
Kurniawan LB. Triglyceride-Glucose Index as A Biomarker of Insulin Resistance, Diabetes Mellitus, Metabolic Syndrome, And Cardiovascular Disease: A Review. EJIFCC. 2024;35(1):44-51. PMID: 38706737; PMCID: PMC11063788.
Dikaiakou E, Vlachopapadopoulou EA, Paschou SA, Athanasouli F, Panagiotopoulos Ι, Kafetzi M, Fotinou A, Michalacos S. Τriglycerides-glucose (TyG) index is a sensitive marker of insulin resistance in Greek children and adolescents. Endocrine. 2020;70(1):58-64. doi: 10.1007/s12020-020-02374-6. PMID: 32557329.
Yoon JS, Lee HJ, Jeong HR, Shim YS, Kang MJ, Hwang IT. Triglyceride glucose index is superior biomarker for predicting type 2 diabetes mellitus in children and adolescents. Endocr J. 2022; 69(5):559-565. doi: 10.1507/endocrj.EJ21-0560. PMID: 34924455.
Nakagomi A, Sunami Y, Kawasaki Y, Fujisawa T, Kobayashi Y. Sex difference in the association between surrogate markers of insulin resistance and arterial stiffness. J Diabetes Complications. 2020; 34(6):107442. doi: 10.1016/j.jdiacomp.2019.107442. PMID: 31668590.
Taghdir M, Salehi A, Parastouei K, Abbaszadeh S. Relationship between diet quality and nonalcoholic fatty liver disease predictor indices in Iranian patients with metabolic syndrome: A cross-sectional study. Food Sci Nutr. 2023; 11(10):6133-6139. doi: 10.1002/fsn3.3549. PMID: 37823171; PMCID: PMC10563747.
Hosseini SA, Shayesteh AA, Hashemi SJ, Rahimi Z, Saki N, Bavi Behbahani H, Cheraghian B, Alipour M. The association between healthy eating index-2015 with anthropometric, cardiometabolic and hepatic indices among patients with non-alcoholic fatty liver disease. BMC Gastroenterol. 2024; 24(1):159. doi: 10.1186/s12876-024-03222-x. PMID: 38724894; PMCID: PMC11084087.
DOI: https://doi.org/10.23857/pc.v9i7.7585
Enlaces de Referencia
- Por el momento, no existen enlaces de referencia
Polo del Conocimiento
Revista Científico-Académica Multidisciplinaria
ISSN: 2550-682X
Casa Editora del Polo
Manta - Ecuador
Dirección: Ciudadela El Palmar, II Etapa, Manta - Manabí - Ecuador.
Código Postal: 130801
Teléfonos: 056051775/0991871420
Email: polodelconocimientorevista@gmail.com / director@polodelconocimiento.com
URL: https://www.polodelconocimiento.com/
